ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

SK Biopharmaceuticals clinical trials

Part of SK Inc., which holds 64.02% as of 2025-12-31. Source

The registry lists 43 studies whose lead sponsor is SK Biopharmaceuticals or one of 1 company grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.

Keep track of what changes. Save the SK Biopharmaceuticals studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
36
Terminated
3
Recruiting
2
Approved for marketing
1
Active, not recruiting
1

Phase

Phase 2
16
Phase 3
14
Phase 1
13
Phase 4
1

Where

United States
26
Poland
9
Korea, Republic of
9
Hungary
8
Spain
6
Australia
5

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to SK Biopharmaceuticals.

  • SK Life Science, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    43 studies →

Focus areas

Conditions SK Biopharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Seizures16Epilepsies, Partial13Epilepsy12

Studies

Recruiting first, then most recently updated. Showing 43 of 43.